title: Regulation of cholesterol metabolism in a slow-growing hepatoma in vivo.
abstract: Cholesterol metabolism and its regulation are altered in hepatomas as compared to normal liver. We investigated parameters of cholesterol metabolism and their regulation in rats bearing the well-differentiated Morris hepatoma 9108. The numbers of membrane associated receptors recognizing chylomicron remnants, the lipoproteins that deliver dietary lipid to the liver, were substantially decreased in the 9108 tumor relative to the host liver. Cholesterol synthetic rates were 2-3-fold higher in the tumor, while the activity of 3-hydroxy-3-methylglutarylcoenzyme A reductase (EC 1.1.1.88), a rate-limiting enzyme for sterol synthesis, was elevated 6-14-fold. Although tumor free and esterified cholesterol contents were elevated, the activity of acylcoenzyme A:cholesterol acyltransferase (EC 2.3.1.26), the enzyme responsible for intracellular sterol esterification, was unchanged. Similar to the host liver, cholesterol synthesis and 3-hydroxy-3-methylglutarylcoenzyme A reductase were inhibited in the tumor when rats were fed a diet containing cholesterol, cholate and lard, and there was no effect on the numbers of chylomicron remnant receptors. Administering an intravenous bolus of very low density lipoproteins obtained from hypercholesterolemic rats caused an inhibition of tumor reductase activity, but had little effect on cholesterol content or cholesterol esterification. Thus, hepatoma 9108 expressed quantitative differences in cellular parameters involved in the uptake, metabolism, and synthesis of cholesterol and their susceptibility to regulation when compared with the host liver. These differences are best explained by changes in the hepatoma of multiple factors involved in the regulation of normal hepatic cholesterol metabolism.
authors.affiliation: Department of Medicine, Stanford University School of Medicine, CA.
authors.forename: S K
authors.initials: SK
authors.lastname: Erickson
authors.forename: A D
authors.initials: AD
authors.lastname: Cooper
authors.forename: G F
authors.initials: GF
authors.lastname: Barnard
authors.forename: C M
authors.initials: CM
authors.lastname: Havel
authors.forename: J A
authors.initials: JA
authors.lastname: Watson
authors.forename: K R
authors.initials: KR
authors.lastname: Feingold
authors.forename: A H
authors.initials: AH
authors.lastname: Moser
authors.forename: M
authors.initials: M
authors.lastname: Hughes-Fulford
authors.forename: M D
authors.initials: MD
authors.lastname: Siperstein
mesh_terms: D000818:Animals; D002784:Cholesterol / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008114:Liver Neoplasms, Experimental / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface / Q000032:analysis; D018110:Receptors, Lipoprotein; D002785:Sterol O-Acyltransferase / Q000378:metabolism
chemical_list: D008055:Lipids; D008074:Lipoproteins; D011956:Receptors, Cell Surface; D018110:Receptors, Lipoprotein; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D002785:Sterol O-Acyltransferase